Boston Scientific Corporation (NYSE: BSX) is a large market cap stock with a market cap of 35.99 B. It is in the Medical Appliances & Equipment industry and sector Healthcare, with a current P/E of 83.51, a forward P/E of 18.47 and EPS of 0.31. At a stock price of 26.14 (0.77%) it has a dividend yield of *TBA.
EPS growth for the last five years have been -2.80%, more recently this last year it has grown by 241.40%. The next year growth is going to be about 13.47% and more long-term 11.25% after five years. EPS growth quarter over quarter is 41.50%. Sales growth for the past five years have been 1.90% and sales growth quarter over quarter is 10.00%.
For performance, Boston Scientific Corporation the past week has seen a gain of -0.87%. For the last month performance for Boston Scientific Corporation is 5.36%. While the last quarter is 3.08% and half year, 23.65%. Finally for the year, performance is 17.27%.
The 52-week high for Boston Scientific Corporation, is at -2.32%, and for the 52-week low it comes to a value of 32.89%. The 20-day simple moving average is 0.02% and 10.61% for the 200-day simple moving average.
Volatility for the week is at 1.34%, and for the month it is 1.33%. Boston Scientific Corporation, has a target price of 29.32.
In terms of debt, long term debt/equity is 0.78, and for total debt/equity Boston Scientific Corporation has 0.78. The gross margin is 71.30%, while operating margin is 6.00%, the profit margin is 5.10%. The current ratio is 0.9 and the quick ratio is 0.6.
Insider ownership is at 0.30%, with instituitional ownership at 93.50%. Boston Scientific Corporation has a payout ratio of 0.00%. With the total shares outstanding coming to 1376.71. The shares float is 1362.23, with the float short at 1.17%, with short ratio coming to 2.14.
In terms of returns, the return on assets see Boston Scientific Corporation, get 2.40%, with its returns on investment at 5.10%. Return on equity is 6.60%. So will the investors see the target price of 29.32, reached soon?
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.
Boston Scientific Corporation (NYSE: BSX)